Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates
Open Access
- 28 February 2003
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 7 (2), 271-280
- https://doi.org/10.1016/s1525-0016(02)00051-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Artificial mammalian gene regulation networks—novel approaches for gene therapy and bioengineeringJournal of Biotechnology, 2002
- The future of human gene therapyMolecular Aspects of Medicine, 2001
- Gene therapy: the first decadeTrends in Biotechnology, 2000
- Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advancesMethods in Enzymology, 2000
- Regulated gene expression systemsGene Therapy, 2000
- Control of Erythropoietin Delivery by Doxycycline in Mice After Intramuscular Injection of Adeno-Associated VectorBlood, 1998
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- Tetracycline-Reversible Silencing of Eukaryotic PromotersMolecular and Cellular Biology, 1995
- The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression.Proceedings of the National Academy of Sciences, 1994
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences, 1992